European Union - English - EMA (European Medicines Agency)

zentiva k.s. - riluzole - amyotrophic lateral sclerosis - other nervous system drugs - riluzole zentiva is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (als).clinical trials have demonstrated that riluzole zentiva extends survival for patients with als. survival was defined as patients who were alive, not intubated for mechanical ventilation and tracheotomy-free.there is no evidence that riluzole zentiva exerts a therapeutic effect on motor function, lung function, fasciculations, muscle strength and motor symptoms. riluzole zentiva has not been shown to be effective in the late stages of als.safety and efficacy of riluzole zentiva has only been studied in als. therefore, riluzole zentiva should not be used in patients with any other form of motor-neurone disease.

Israel - English - Ministry of Health

sanofi israel ltd - riluzole - film coated tablets - riluzole 50 mg - riluzole - riluzole - rilutek is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (als).

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - riluzole - coated tablet - riluzole 50 mg - other nervous system drugs

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - riluzole - amyotrophic lateral sclerosis - other nervous system drugs - rilutek is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (als).clinical trials have demonstrated that rilutek extends survival for patients with als.survival was defined as patients who were alive, not intubated for mechanical ventilation and tracheotomy-free.there is no evidence that rilutek exerts a therapeutic effect on motor function, lung function, fasciculations, muscle strength and motor symptoms.rilutek has not been shown to be effective in the late stages of als.safety and efficacy of rilutek has only been studied in als. therefore, rilutek should not be used in patients with any other form of motor-neurone disease.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - riluzole - tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - riluzole - tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharmaceutical industries europe b.v. - riluzole - tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - riluzole - tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - riluzole - oral suspension - 5mg/1ml

Israel - English - Ministry of Health

megapharm ltd - riluzole - suspension - riluzole 5 mg / 1 ml - riluzole - teglutik 5 mg/ml oral suspension is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (als).